Induction of senescence-associated secretory phenotype underlies the therapeutic efficacy of PRC2 inhibition in cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Induction of senescence-associated secretory phenotype underlies the therapeutic efficacy of PRC2 inhibition in cancer
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 13, Issue 2, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-02-16
DOI
10.1038/s41419-022-04601-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Somatic mutations and single-cell transcriptomes reveal the root of malignant rhabdoid tumours
- (2021) Lars Custers et al. Nature Communications
- Mechanisms of Macrophage Plasticity in the Tumor Environment: Manipulating Activation State to Improve Outcomes
- (2021) Tiffany Davia Ricketts et al. Frontiers in Immunology
- Senescent mesenchymal stem cells remodel extracellular matrix driving breast cancer cells to a more-invasive phenotype
- (2020) Deepraj Ghosh et al. JOURNAL OF CELL SCIENCE
- SciPy 1.0: fundamental algorithms for scientific computing in Python
- (2020) Pauli Virtanen et al. NATURE METHODS
- Cytokine-Induced Guanylate Binding Protein 1 (GBP1) Release from Human Ovarian Cancer Cells
- (2020) Grazia Carbotti et al. Cancers
- The SWI/SNF complex in cancer — biology, biomarkers and therapy
- (2020) Priya Mittal et al. Nature Reviews Clinical Oncology
- Drugging histone methyltransferases in cancer
- (2020) Laia Richart et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Classical and Nonclassical Intercellular Communication in Senescence and Ageing
- (2020) Juan Antonio Fafián-Labora et al. TRENDS IN CELL BIOLOGY
- Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study
- (2020) Mrinal Gounder et al. LANCET ONCOLOGY
- Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial
- (2020) Franck Morschhauser et al. LANCET ONCOLOGY
- Cellular Senescence Variation by Metabolic and Epigenomic Remodeling
- (2020) Mitsuyoshi Nakao et al. TRENDS IN CELL BIOLOGY
- Senescent cells and macrophages: key players for regeneration?
- (2020) Sonia S. Elder et al. Open Biology
- L1 drives IFN in senescent cells and promotes age-associated inflammation
- (2019) Marco De Cecco et al. NATURE
- R-Loops Enhance Polycomb Repression at a Subset of Developmental Regulator Genes
- (2019) Konstantina Skourti-Stathaki et al. MOLECULAR CELL
- PRC2 is high maintenance
- (2019) Jia-Ray Yu et al. GENES & DEVELOPMENT
- Molecular Mechanisms Directing PRC2 Recruitment and H3K27 Methylation
- (2019) Anne Laugesen et al. MOLECULAR CELL
- An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer
- (2019) Marian L. Burr et al. CANCER CELL
- Basement membrane collagens and disease mechanisms
- (2019) Anna Gatseva et al. Essays in Biochemistry
- Cellular Senescence: Defining a Path Forward
- (2019) Vassilis Gorgoulis et al. CELL
- Targeting Excessive EZH1 and EZH2 Activities for Abnormal Histone Methylation and Transcription Network in Malignant Lymphomas
- (2019) Makoto Yamagishi et al. Cell Reports
- Binding Modes of Small‐Molecule Inhibitors to the EED Pocket of PRC2
- (2019) Dading Huang et al. CHEMPHYSCHEM
- Development and Validation of an RNA-Seq-Based Prognostic Signature in Neuroblastoma
- (2019) Jian-Guo Zhou et al. Frontiers in Oncology
- KDM6B counteracts EZH2-mediated suppression of IGFBP5 to confer resistance to PI3K/AKT inhibitor treatment in breast cancer
- (2018) Wenyu Wang et al. MOLECULAR CANCER THERAPEUTICS
- Regulation of Cellular Senescence by Polycomb Chromatin Modifiers through Distinct DNA Damage- and Histone Methylation-Dependent Pathways
- (2018) Takahiro Ito et al. Cell Reports
- Targeting Epigenetic Crosstalk as a Therapeutic Strategy for EZH2-Aberrant Solid Tumors
- (2018) Xun Huang et al. CELL
- The dynamic nature of senescence in cancer
- (2018) Soyoung Lee et al. NATURE CELL BIOLOGY
- 20(S)-Ginsenoside Rh2 suppresses proliferation and migration of hepatocellular carcinoma cells by targeting EZH2 to regulate CDKN2A-2B gene cluster transcription
- (2017) Qi Li et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2
- (2017) Liying Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Selective Killing of SMARCA2- and SMARCA4-deficient Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cells by Inhibition of EZH2: In Vitro and In Vivo Preclinical Models
- (2017) Elayne Chan-Penebre et al. MOLECULAR CANCER THERAPEUTICS
- An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED
- (2017) Wei Qi et al. Nature Chemical Biology
- EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas
- (2017) Faizaan Mohammad et al. NATURE MEDICINE
- Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2
- (2017) Lian Dee Ler et al. Science Translational Medicine
- EZH2 enables germinal centre formation through epigenetic silencing of CDKN1A and an Rb-E2F1 feedback loop
- (2017) Wendy Béguelin et al. Nature Communications
- Acquired Tissue-Specific Promoter Bivalency Is a Basis for PRC2 Necessity in Adult Cells
- (2016) Unmesh Jadhav et al. CELL
- MLL1 is essential for the senescence-associated secretory phenotype
- (2016) Brian C. Capell et al. GENES & DEVELOPMENT
- Expression of ANRIL-Polycomb Complexes-CDKN2A/B/ARF Genes in Breast Tumors: Identification of a Two-Gene (EZH2/CBX7) Signature with Independent Prognostic Value
- (2016) D. Meseure et al. MOLECULAR CANCER RESEARCH
- Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
- (2016) Darren J. Baker et al. NATURE
- An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation
- (2016) George P Souroullas et al. NATURE MEDICINE
- deepTools2: a next generation web server for deep-sequencing data analysis
- (2016) Fidel Ramírez et al. NUCLEIC ACIDS RESEARCH
- BRD4 Connects Enhancer Remodeling to Senescence Immune Surveillance
- (2016) N. Tasdemir et al. Cancer Discovery
- PRC2 Epigenetically Silences Th1-Type Chemokines to Suppress Effector T-Cell Trafficking in Colon Cancer
- (2015) Nisha Nagarsheth et al. CANCER RESEARCH
- Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
- (2015) Dongjun Peng et al. NATURE
- The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4
- (2015) C. Kang et al. SCIENCE
- Senescence-associated inflammatory responses: aging and cancer perspectives
- (2015) Audrey Lasry et al. TRENDS IN IMMUNOLOGY
- Inhibition of histone methyltransferase EZH2 depletes leukemia stem cell of mixed lineage leukemia fusion leukemia through upregulation of p16
- (2014) Koki Ueda et al. CANCER SCIENCE
- Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in EZH2-Mutant Non-Hodgkin Lymphoma
- (2014) S. K. Knutson et al. MOLECULAR CANCER THERAPEUTICS
- MiR-138 Induces Renal Carcinoma Cell Senescence by Targeting EZH2 and Is Downregulated in Human Clear Cell Renal Cell Carcinoma
- (2014) Jiaqian Liang et al. ONCOLOGY RESEARCH
- featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
- (2013) Y. Liao et al. BIOINFORMATICS
- EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation
- (2013) Wendy Béguelin et al. CANCER CELL
- A Senescence-Inflammatory Switch from Cancer-Inhibitory to Cancer-Promoting Mechanism
- (2013) Ariel Pribluda et al. CANCER CELL
- Chromatin modifiers and remodellers: regulators of cellular differentiation
- (2013) Taiping Chen et al. NATURE REVIEWS GENETICS
- Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2
- (2013) S. K. Knutson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EZH2 Regulates the Expression of p16 in the Nasopharyngeal Cancer Cells
- (2013) Jing Zhong et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Twist-1 Induces Ezh2 Recruitment Regulating Histone Methylation along the Ink4A/Arf Locus in Mesenchymal Stem Cells
- (2012) D. Cakouros et al. MOLECULAR AND CELLULAR BIOLOGY
- EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
- (2012) Michael T. McCabe et al. NATURE
- A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells
- (2012) Sarah K Knutson et al. Nature Chemical Biology
- Fast gapped-read alignment with Bowtie 2
- (2012) Ben Langmead et al. NATURE METHODS
- Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation
- (2012) W. Qi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications
- (2011) Felix Krueger et al. BIOINFORMATICS
- Tumor Suppressor and Aging Biomarker p16INK4aInduces Cellular Senescence without the Associated Inflammatory Secretory Phenotype
- (2011) Jean-Philippe Coppé et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Polycomb complex PRC2 and its mark in life
- (2011) Raphaël Margueron et al. NATURE
- Epigenetic Antagonism between Polycomb and SWI/SNF Complexes during Oncogenic Transformation
- (2010) Boris G. Wilson et al. CANCER CELL
- Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
- (2010) Ryan D Morin et al. NATURE GENETICS
- Polycomb protein Ezh2 regulates pancreatic -cell Ink4a/Arf expression and regeneration in diabetes mellitus
- (2009) H. Chen et al. GENES & DEVELOPMENT
- Ndy1/KDM2B immortalizes mouse embryonic fibroblasts by repressing theInk4a/Arflocus
- (2009) Alexandros Tzatsos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started